EXOZ
eXoZymesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About EXOZ
Exozymes Inc.
A biomanufacturing company dedicated to efficiently converting natural or renewable resources into high-value chemicals using cell-free multi-step enzyme systems
750 Royal Oaks Drive, Suite 106, Monrovia, CA 91016
--
EXoZymes Inc., was founded in Nevada in 2019. EXoZymes was established to use natural building blocks to create molecules of interest, effectively simplifying nature. EXoZymes is a biotechnology development company and a majority-owned subsidiary. EXoZymes' technology is a differentiated and unique synthetic biology platform designed to enable scalable exploration of a large number of molecules and properties found in nature.
Company Financials
EPS
EXOZ has released its 2025 Q3 earnings. EPS was reported at -0.27, versus the expected 0, missing expectations. The chart below visualizes how EXOZ has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
